Developer docs
API playgroundTry for free, no card

Search company profiles

Biovet JSCo

Full company profile

uuid003zmu6

Namestring
Biovet JSCo
Legal namestring
Biovet JSCo
Websiteurl
biovet.com
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Biovet JSCo is a joint stock company founded in 1961 with a current headcount of 81 employees. The "JSCo" legal designation indicates a joint stock corporate structure, a form historically common in Eastern European jurisdictions, and the "Biovet" naming convention signals a veterinary and biological products orientation, though the source data does not enumerate actual products, manufacturing facilities, or therapeutic/diagnostic categories served.

Beyond founding year, legal form, and headcount, the input record for Biovet JSCo is sparse. The company's primary public website, biovet.com, returned only a verification/captcha page during the source capture window, so no product catalog, pricing model, customer base, geographic footprint, distribution channels, leadership team, ownership structure, regulatory standing, certifications, partnerships, or financial figures could be verified from publicly available web content. No management team, no funding history, no M&A activity, no strategic transactions, and no growth metrics are documented in the supplied data. The resulting picture is that of a small, long-established corporate entity whose operating posture, customer concentration, and product surface cannot be characterized from the input alone.

Short descriptiontext

Biovet JSCo is a joint stock company founded in 1961 with 81 employees, operating in the veterinary and biological products domain based on its corporate name. No further product, customer, or market detail is available in the source data.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
Markets served

Serves global market

Keyword5 values
veterinary biologicals, animal health products, biotechnology manufacturing, veterinary pharmaceuticals, biological preparations
Industry2 codes
1Biologic API/Drug Substance Manufacturing Services
CodeHLAAAKAAPrimaryYes
2Veterinary Public Health, Biosecurity & Disease Control Services
CodeAFAEANAIPrimaryNo
NAICS code1 code
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code2 codes
  • Biological Products, (No Disgnostic Substances)2836
  • Pharmaceutical Preparations2834
Product category
Veterinary Biologicals
Social media profiles1 record
Cost components5 values
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Biovet JSCo is a joint-stock company whose name combines "Bio" and "vet," indicating it operates in the veterinary biologicals/biotechnology sector, likely manufacturing and selling animal health products such as vaccines or biological preparations. The company's own website content could not be retrieved during this analysis (returned only a verification/captcha page), so the specific product mix and customer details could not be confirmed from primary sources.

Differentiator
Functional benefit
Problem solved
No data
Peers10 records
TypeDirect peer
Description

Phibro Animal Health is a publicly traded animal health company producing vaccines, pharmaceuticals, and nutrition products for livestock and poultry. Comparable to Biovet by virtue of overlapping biologics manufacturing and animal health distribution.

TypeDirect peer
Description

IDT Biologika is a German veterinary biologicals manufacturer producing vaccines and biopharmaceuticals for animal health. It is a directly comparable European CDMO and vaccine producer with overlapping biomanufacturing capabilities and target customer base.

TypeDirect peer
Description

Bioveta is a Czech veterinary biologics and pharmaceutical manufacturer with a directly comparable product scope (animal vaccines, sera, diagnostics) and similar corporate heritage. It is the closest parallel to Biovet JSCo by name, geography (Central/Eastern Europe), and product focus.

TypeBroad incumbent
Description

Virbac is a French global animal health company offering veterinary vaccines, pharmaceuticals, and diagnostics. It is a broad incumbent in the animal health biologics space with substantially greater scale and geographic reach than Biovet.

TypeBroad incumbent
Description

Elanco is a global animal health company offering vaccines, pharmaceuticals, and nutrition. It is a broad incumbent in the veterinary biologics category with substantial scale advantages versus Biovet.

TypeDirect peer
Description

Ceva is a leading veterinary pharmaceutical and biologicals company specializing in animal vaccines, pharmaceuticals, and diagnostics. It is a direct peer in veterinary biologics manufacturing with a global footprint and a similar specialty positioning.

TypeBroad incumbent
Description

Merck Animal Health is a global animal health division of Merck & Co., producing vaccines, anti-infectives, and parasiticides. It is a broad incumbent operating across the same veterinary biologics space as Biovet.

TypeBroad incumbent
Description

Zoetis is the world's largest animal health company, offering vaccines, diagnostics, and pharmaceuticals across species. It is a broad incumbent in veterinary biologics and the dominant benchmark for scale in the sector.

TypeBroad incumbent
Description

Vetoquinol is a French veterinary pharmaceutical company producing animal health products including biologics and pharmaceuticals. It is a broad incumbent similar in category to Biovet but with global distribution and a larger product portfolio.

TypeBroad incumbent
Description

Boehringer Ingelheim's Animal Health division is a global leader in veterinary vaccines and biologicals. It is a broad incumbent that competes with Biovet in the broader veterinary biologics category.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Biovet JSCo

Veterinary Biologicalsbiovet.com

Biovet JSCo is a joint stock company founded in 1961 with 81 employees, operating in the veterinary and biological products domain based on its corporate name. No further product, customer, or market detail is available in the source data.

What Biovet JSCo does

Biovet JSCo is a joint stock company founded in 1961 with a current headcount of 81 employees. The "JSCo" legal designation indicates a joint stock corporate structure, a form historically common in Eastern European jurisdictions, and the "Biovet" naming convention signals a veterinary and biological products orientation, though the source data does not enumerate actual products, manufacturing facilities, or therapeutic/diagnostic categories served.

Beyond founding year, legal form, and headcount, the input record for Biovet JSCo is sparse. The company's primary public website, biovet.com, returned only a verification/captcha page during the source capture window, so no product catalog, pricing model, customer base, geographic footprint, distribution channels, leadership team, ownership structure, regulatory standing, certifications, partnerships, or financial figures could be verified from publicly available web content. No management team, no funding history, no M&A activity, no strategic transactions, and no growth metrics are documented in the supplied data. The resulting picture is that of a small, long-established corporate entity whose operating posture, customer concentration, and product surface cannot be characterized from the input alone.

Biovet JSCo firmographics

Firmographics
Name
Biovet JSCo
Legal name
Biovet JSCo
Website
https://biovet.com
Company type
Private
Operating status
Operating
Headcount range
51–100 employees
Short description
Biovet JSCo is a joint stock company founded in 1961 with 81 employees, operating in the veterinary and biological products domain based on its corporate name. No further product, customer, or market detail is available in the source data.
Ownership category
akta.pro rank

Biovet JSCo industry classification

Industry
Product category
Veterinary Biologicals
NAICS
Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834)
akta.pro primary industry
Biologic API/Drug Substance Manufacturing Services (HLAAAKAA)
akta.pro secondary industry
Veterinary Public Health, Biosecurity & Disease Control Services (AFAEANAI)

Keywords

  • Veterinary biologicals
  • Animal health products
  • Biotechnology manufacturing
  • Veterinary pharmaceuticals
  • Biological preparations

Biovet JSCo business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure

Biovet JSCo product offering

Product offering

Core offering

Biovet JSCo is a joint-stock company whose name combines "Bio" and "vet," indicating it operates in the veterinary biologicals/biotechnology sector, likely manufacturing and selling animal health products such as vaccines or biological preparations. The company's own website content could not be retrieved during this analysis (returned only a verification/captcha page), so the specific product mix and customer details could not be confirmed from primary sources.

Differentiator

Problem solved

Functional benefit

Companies that use Biovet JSCo

Customer profile

Ideal customer profiles1 record

Biovet JSCo technology and API

Technology

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Biovet JSCo competitors and assessment

Company assessment

Direct peers

  • Phibro Animal Health: Phibro Animal Health is a publicly traded animal health company producing vaccines, pharmaceuticals, and nutrition products for livestock and poultry. Comparable to Biovet by virtue of overlapping biologics manufacturing and animal health distribution.
  • IDT Biologika: IDT Biologika is a German veterinary biologicals manufacturer producing vaccines and biopharmaceuticals for animal health. It is a directly comparable European CDMO and vaccine producer with overlapping biomanufacturing capabilities and target customer base.
  • Bioveta: Bioveta is a Czech veterinary biologics and pharmaceutical manufacturer with a directly comparable product scope (animal vaccines, sera, diagnostics) and similar corporate heritage. It is the closest parallel to Biovet JSCo by name, geography (Central/Eastern Europe), and product focus.
  • Ceva Santé Animale: Ceva is a leading veterinary pharmaceutical and biologicals company specializing in animal vaccines, pharmaceuticals, and diagnostics. It is a direct peer in veterinary biologics manufacturing with a global footprint and a similar specialty positioning.

Broad incumbents

  • Virbac: Virbac is a French global animal health company offering veterinary vaccines, pharmaceuticals, and diagnostics. It is a broad incumbent in the animal health biologics space with substantially greater scale and geographic reach than Biovet.
  • Elanco Animal Health: Elanco is a global animal health company offering vaccines, pharmaceuticals, and nutrition. It is a broad incumbent in the veterinary biologics category with substantial scale advantages versus Biovet.
  • Merck Animal Health: Merck Animal Health is a global animal health division of Merck & Co., producing vaccines, anti-infectives, and parasiticides. It is a broad incumbent operating across the same veterinary biologics space as Biovet.
  • Zoetis: Zoetis is the world's largest animal health company, offering vaccines, diagnostics, and pharmaceuticals across species. It is a broad incumbent in veterinary biologics and the dominant benchmark for scale in the sector.
  • Vetoquinol: Vetoquinol is a French veterinary pharmaceutical company producing animal health products including biologics and pharmaceuticals. It is a broad incumbent similar in category to Biovet but with global distribution and a larger product portfolio.
  • Boehringer Ingelheim Animal Health: Boehringer Ingelheim's Animal Health division is a global leader in veterinary vaccines and biologicals. It is a broad incumbent that competes with Biovet in the broader veterinary biologics category.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

Biovet JSCo social profiles

Digital presence

Biovet JSCo financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Biovet JSCo leadership team

Management profile

Number of profiles

Biovet JSCo funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Biovet JSCo M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biovet JSCo

What does Biovet JSCo do?

Biovet JSCo is a joint-stock company whose name combines "Bio" and "vet," indicating it operates in the veterinary biologicals/biotechnology sector, likely manufacturing and selling animal health products such as vaccines or biological preparations. The company's own website content could not be retrieved during this analysis (returned only a verification/captcha page), so the specific product mix and customer details could not be confirmed from primary sources.

Is Biovet JSCo a public or private company?

Biovet JSCo is a private company. It is classified as unknown and is currently operating.

When was Biovet JSCo founded?

Biovet JSCo was founded in -1. It employs 51 to 100 people.

Who are Biovet JSCo's main competitors?

Direct peers on record are Phibro Animal Health, IDT Biologika, Bioveta and Ceva Santé Animale. Broad incumbents are Virbac, Elanco Animal Health, Merck Animal Health, Zoetis, Vetoquinol and Boehringer Ingelheim Animal Health.

Does Biovet JSCo have an API?

No public API is recorded for Biovet JSCo.

What industry is Biovet JSCo in?

Biovet JSCo's product category is Veterinary Biologicals. Its primary akta.pro industry code is HLAAAKAA, Biologic API/Drug Substance Manufacturing Services, with a secondary code of AFAEANAI, Veterinary Public Health, Biosecurity & Disease Control Services. Its NAICS code is 325414 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales